# Oberland Capital: portfolio, investments and team > Oberland Capital is a private credit based in United States. 5 investments on record, 1 in the last 12 months, latest Jan 2026. Source: https://millionrounds.com/fund/oberland-capital (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Oberland Capital Last cheque observed Jan 2026; 5 cheques on record. Deploying now New fund $10M, Nov 2025 Private credit Growth Healthcare Life Sciences Deploying now **50%** of best year **1** **cheques in 12 months**, 5 on record Since the last cheque **274** days **00** hrs **00** min **00** sec Median round **$140M** Cheque size, as they say **$50M – $300M** Rounds led **3 of 5** Sole investor **4 rounds** Mostly in **United States, 100%** Pitch Oberland Capital ## Oberland Capital highlights - 01 1 cheques in the last 12 months - 02 Mostly Debt and Series B: 100% of its rounds - 03 Sole investor in 4 rounds, median $145M ## What they do > Oberland Capital’s broad suite of creative financing solutions includes monetization of royalty streams, acquisition of future product revenues, creation of project-based financing structures, and investments in traditional debt and equity. From their own website - **Type:** Private credit - **Cheque size:** $50M – $300M as they say - **Stages:** Growth - **Sectors:** Healthcare Life Sciences - **Based in:** New York, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **5 appearances** - **2026** 1 round - **Jan** **[Primmune Therapeutics](https://millionrounds.com/company/primmune-therapeutics)** Series B · US · Bioqube Ventures **$8.6M** With 3 others - **2024** 2 rounds - **Sept** **[BillionToOne](https://millionrounds.com/company/billiontoone)** Debt · US · Firms' own news pages **$140M** *Led* - **Jan** **[ImmunityBio, Inc.](https://millionrounds.com/company/immunitybio-inc)** US · Firms' own news pages **$320M** *Led* - **2023** 1 round - **May** **[Humacyte, Inc.](https://millionrounds.com/company/humacyte-inc)** Debt · US · Firms' own news pages **$150M** *Led* - **2017** 1 round - **Oct** **[Impact Biomedicines](https://millionrounds.com/company/impact-biomedicines)** US · FinSMEs **$90M** Sole investor An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **5 named** AD **Andrew David Rubinstein** Managing member of the general partner i Filing they signed DD **David Dubinsky** CFO i Form ADV JN **Jean-Pierre Naegeli** Managing member of the general partner i Filing they signed KE **Kristian Erik Wiggert** CCO i Form ADV WP **William Paul Clifford** Member i Form ADV We also hold **13** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$3.2B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Oberland Capital Management LLC - **SEC number:** CRD 169109 Funds on its Form ADV **8** private funds, **$3.1B** in gross assets · filed Mar 2024 Private equity **7** Hedge **1** - Oberland Capital Healthcare Master Fund III L.P. *Private equity* 275 investors $1.2B - Oberland Capital Healthcare Solutions Master Fund L.P. *Private equity* 223 investors $602M - Oberland Capital Healthcare Master Fund II L.P. *Private equity* 759 investors $601M - Oberland Capital Healthcare Solutions Co-Invest Master Fund L.P. *Private equity* 177 investors $371M - Oberland Orion Co-Invest Fund L.P. *Private equity* 2 investors $200M - Oberland Capital Healthcare Master Fund L.P. *Private equity* 357 investors $104M - Oberland Capital Healthcare III Brazos Co-Invest L.P. *Private equity* 2 investors $56M - Quantbio Innovations Fund L.P. *Hedge* 14 investors $6.0M ## What they claim to have backed From their own portfolio page (on their website) **2** of 16 we have independently watched raise [COMPANY](https://millionrounds.com/company/humacyte)[COMPANY](https://millionrounds.com/company/billiontoone) COMPANY COMPANY COMPANY COMPANY COMPANY COMPANY COMPANY COMPANY COMPANY COMPANY Company Company Company Company Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. New fund on file **$10M** raised in Nov 2025 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Growth Median round joined **$140M** the round, not its cheque Alone, median **$145M** Led 3 of 5 rounds **60%** - **Said size:** $50M – $300M - **Sole investor:** 4 rounds - **Last cheque:** Jan 2026 Rounds by stage said on their site - Debt *2* - Series B *1* - Growth said *-* Cheques by month Led Joined Nov 2023 Oct 2026 **Pitching Oberland Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Recently backed The latest companies Oberland Capital put money into. [**Primmune Therapeutics** $8.6M · Jan 2026](https://millionrounds.com/company/primmune-therapeutics)[**BillionToOne** $140M · Sept 2024](https://millionrounds.com/company/billiontoone) ## Quick answers about Oberland Capital ### What does Oberland Capital invest in? Oberland Capital invests most often at Debt and Series B (100% of the rounds on record), in sectors such as Healthcare and Life Sciences. ### How active is Oberland Capital? 5 investments on record, 1 of them in the last 12 months, and it led 3. The most recent was in Jan 2026. ### What has Oberland Capital invested in recently? Its most recent investments on record: Primmune Therapeutics (Series B, Jan 2026), BillionToOne (Debt, Sept 2024) and ImmunityBio, Inc. (Undisclosed round, Jan 2024). ### How big are Oberland Capital's cheques? The median round it joins is $140M. It says it writes cheques of $50M to $300M. ### Does Oberland Capital lead rounds? Yes: it led 3 of its 5 investments on record (60%). ### Where does Oberland Capital invest? Most of the companies it backs are in the United States (100%). ### Is Oberland Capital investing now? Yes: it is actively investing, with 1 investments in the last 12 months. ### What kind of investor is Oberland Capital? Oberland Capital is a private credit firm based in New York, United States. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=oberland-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=oberland-capital)